Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

Clinical trial NCT01441869 · COMPLETED

Trial details

NCT number: NCT01441869
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and Metformin

Start date: 2011-10-01
Primary completion: 2011-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.